Table 1 Characteristics of the overall population (n = 246)
General data | |
|---|---|
Age, years | 59 ± 15 |
Male sex, n (%) | 144 (58.6) |
BMI, Kg/m2 | 25.7 ± 3.6 |
Diabetes, n (%) | 41 (16.7) |
Dyslipidaemia, n (%) | 97 (40) |
Clinic SBP, mmHg | 145.6 ± 16.9 |
Clinic DBP, mmHg | 87.1 ± 9.8 |
24 h mean SBP, mmHg | 129.1 ± 13.1 |
24 h mean DBP, mmHg | 78.1 ± 8.9 |
Echocardiographic data | |
Septal thickness, mm | 10.1 ± 1.6 |
LVPW, mm | 9.8 ± 1.6 |
RWT | 0.41 ± 0.06 |
LVEDd, mm | 48.6 ± 4.1 |
LV mass, g | 172.1 ± 47.9 |
LV mass/BSA, g/m2 | 93.2 ± 23.8 |
LV mass/h2,7, g/m2,7 | 39.6 ± 13.1 |
LA vol/h2, ml/m2 | 15.3 ± 3.4 |
LVEF, % | 67.5 ± 9.7 |
Pharmacological therapy | |
ACEi, n (%) | 46 (18.6) |
ARB, n (%) | 111 (45) |
Calcium channel blockers, n (%) | 93 (37.7) |
Thiazide diuretics, n (%) | 64 (26) |
Beta-blockers, n (%) | 55 (22.5) |
MRA, n (%) | 11 (4.3) |
Combination therapy, n (%) | 126 (51) |
2 drugs, n (%) | 88 (35.6) |
3 drugs, n (%) | 27 (11) |
4 drugs, n (%) | 11 (4.5) |